We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Reset all filters
01 20Alfred E Tiefenbacher GmbH
02 5Pharmathen SA
03 92care4
04 6Abiogen Pharma Spa
05 7Actavis Inc
06 3Alkem Laboratories
07 9Collegium Pharmaceutical
08 8ENDO OPERATIONS LTD.
09 7G.L. Pharma Gmbh
10 5GL Pharma
11 73Grunenthal
12 11Grünenthal GmbH
13 2Health Biotech
14 2Hubei Gedian Humanwell Pharmaceutical
15 5Johnson & Johnson Innovative Medicine
16 3Krka
17 6Medical Valley
18 3Novagen Healthcare
19 10ORIFARM GROUP AS
20 9Orchid Pharma
21 7Precise Group
22 2RHODES PHARMACEUTICALS LP
23 3ROXANE
24 5Sandoz B2B
25 5Seqirus
26 1Vega Biotech Pvt. Ltd.
27 4West-ward Pharmaceutical Corp
28 12Blank
Reset all filters
01 1Antic-calc Tablet, Film Coated
02 30Depot tablet
03 7ER TABLET
04 4ER Tablet
05 10Extended Release Tablets
06 15Extended-Release Tablet
07 23Film Coated Tablet
08 2Mixture, solution
09 8Oral Solution
10 5Prolonged Release Tablet
11 2SOLUTION;ORAL
12 12SR Tablet
13 3SRT
14 4Solution
15 2TAB
16 3TABLET
17 5TABLET (EXTENDED-RELEASE)
18 3TABLET (IMMEDIATE RELEASE)
19 14TABLET, EXTENDED RELEASE;ORAL
20 2TABLET; ORAL
21 12TABLET;ORAL
22 53Tablet
23 1Tablet, film-coated
24 1Tapentadolo 100Mg 30 Joined' Oral Use Rp
25 1Tapentadolo 150Mg 30 Joined' Oral Use Rp
26 1Tapentadolo 200Mg 30 Joined' Oral Use Rp
27 1Tapentadolo 250Mg 30 Joined' Oral Use Rp
28 1Tapentadolo 25Mg 40 Combined Oral Use Rp
29 1Tapentadolo 50Mg 30 Joined' Oral Use Rp
30 10XR Tablet
31 5Blank
Reset all filters
01 26Approved
02 23Authorized
03 2Cancelled
04 1DISCN
05 34Deregistered
06 2EU Dossier Readiness-Q1 2020
07 4EU Dossier Readiness-Q3 2019
08 8Generic
09 9Generic EU CTD
10 8NARCOTICS (CDSA I)
11 5Originator
12 8RX
13 14Status- Early Development
14 12Under registration in India
15 86Blank
Reset all filters
01 3Ationdo
02 6Ationdo Depot
03 4NUCYNTA
04 5NUCYNTA ER
05 5NUCYNTA EXTENDED-RELEASE
06 3NUCYNTA IR
07 21Palexia
08 1Palexia 100 mg
09 1Palexia 50 mg
10 25Palexia Depot
11 6Palexia Retard
12 5Palexia SR
13 1Palexia SR 100 mg
14 1Palexia SR 200 mg
15 1Palexia SR 50 mg
16 20Palexia depot
17 5TADOMON
18 5TAPELOD
19 16TAPENTADOL
20 5TAPENTADOL HYDROCHLORIDE
21 1Tapencet ER
22 6Tapentadol Depot Abiogen
23 6Tapentadol Depot G.L. Pharma
24 6Tapentadol Depot Medical Valley
25 1Tapentadol Gl Pharma
26 3Tapentadol Krka
27 10Yantil
28 6Yantil Depot
29 6Yantil Retard
30 58Blank
Reset all filters
01 5Australia
02 8Canada
03 20Germany
04 5Greece
05 34India
06 16Italy
07 34Norway
08 5South Africa
09 25Spain
10 60Sweden
11 30USA
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 4MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 4MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany